Radiopharmaceuticals: Technologies and Global Markets

Report Scope

This report analyzes the global market for radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers understand the market, to assess business/growth strategies, and to make informed business decisions regarding radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and 2024 and forecasts values for 2025 through 2029. The radiopharmaceuticals market segmentation is based on product, application, production method, countries and regions.

Drivers, restraints and opportunities in the radiopharmaceuticals market are also discussed. The report also describes the competitive landscape of the radiopharmaceuticals market and highlights emerging trends. The latest new products, acquisitions, and collaborations related to the radiopharmaceuticals market are also covered.

Report Includes

50 data tables and 68 additional tables

Analyses of trends in the global market for radiopharmaceuticals, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029

Estimates of the size, and revenue prospects for, the global market, along with a market share analysis by product type, application, production method, and region/country

Facts and figures pertaining to the market dynamics, technological progress, regulations, prospects, innovations and the impact of various macroeconomic factors

Insights derived from the Porter’s Five Forces model, as well as global supply/value chain and PESTLE analyses

An analysis of patents, clinical trials, emerging trends and other developments in the industry

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

Profiles of leading companies, including Cardinal Health, Lantheus, Curium, GE Healthcare, and Novartis AG

Companies Mentioned

BAYER AG
BLUE EARTH DIAGNOSTICS
BOSTON SCIENTIFIC CORP.
BWXT MEDICAL LTD.
CARDINAL HEALTH
CURIUM
ECKERT & ZIEGLER
GE HEALTHCARE
INTERNATIONAL ISOTOPES INC.
IONETIX CORP.
JUBILANT PHARMOVA LTD.
LANTHEUS
NMR
NOVARTIS AG
SIEMENS HEATHNIEERS AG


Chapter 1 Executive Summary
Market Outlook
Scope Of Report
Market Summary
Chapter 2 Market Overview
Radiopharmaceuticals Overview
Preparation Of Radiopharmaceuticals
Macroeconomic Factors Analysis
Porter’s Five Forces Analysis
Threat Of New Entrants (Moderate To Low)
Threat Of Substitutes (Low To Moderate)
Bargaining Power Of Suppliers (High)
Bargaining Power Of Buyers (Moderate)
Industry Rivalry (Moderate)
Chapter 3 Market Dynamics
Market Drivers
Rising Prevalence Of Cancer And Other Chronic Diseases
Unmet Need In Oncology
Precision Medicine
Nuclear Imaging Technologies
Increasing Investment
Market Restraints
Manufacturing And Supply Chain Issues
Infrastructure And Specialized Imaging Equipment Requirements
Shortage Of Skilled Professionals
Market Trends
Theranostics
Regional Diversification And Supply Chain Resilience
Opportunities
Radiopharmaceuticals Contract Manufacturing
Pet Imaging In Ad
Chapter 4 Regulatory Landscape
U.S.
European Union
Japan
Chapter 5 Emerging Technologies And Developments
Emerging Technologies
Ac-225 And Pb-212
Nanoparticle-based Theranostic Agents
Clinical Trials Analysis
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Patent Analysis
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Radiopharmaceuticals Market, By Product Type
Diagnostic Radiopharmaceuticals
Diagnostic Radiopharmaceuticals Market, By Imaging Technique Type
Diagnostic Radiopharmaceuticals Market, By Production Method
Therapeutic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals Market, By Product Type
Radiopharmaceuticals Market By Application
Market Overview
Oncology
Cardiology
Neurology
Others
Radiopharmaceuticals Market By Radioisotope Production Method
Market Overview
Market Revenue And Forecast
Geographic Breakdown
Radiopharmaceuticals Market Breakdown By Region
North America
Europe
Asia-pacific
Row
Chapter 7 Competitive Intelligence
Overview
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Chapter 8 Sustainability In Radiopharmaceuticals Market: Esg Perspective
Role Of Esg In The Radiopharmaceuticals Industry
Environment
Social
Governance
Esg Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
Bayer Ag
Blue Earth Diagnostics
Boston Scientific Corp.
Bwxt Medical Ltd.
Cardinal Health
Curium
Eckert & Ziegler
Ge Healthcare
International Isotopes Inc.
Ionetix Corp.
Jubilant Pharmova Ltd.
Lantheus
Nmr
Novartis Ag
Siemens Heathnieers Ag
Emerging Start-ups/Market Disruptors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings